Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study

Jiaqi Di,1 Xuanlin Li,1 Jingjing Yang,1 Luguang Li,2 Xueqing Yu2 1Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P.R, Henna University of Chinese Medicine, Zhengzhou, 450046, People’s Republic of China; 2Department o...

Full description

Bibliographic Details
Main Authors: Di J, Li X, Yang J, Li L, Yu X
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Risk Management and Healthcare Policy
Subjects:
Online Access:https://www.dovepress.com/bias-and-reporting-quality-of-clinical-prognostic-models-for-idiopathi-peer-reviewed-fulltext-article-RMHP
_version_ 1811244832834715648
author Di J
Li X
Yang J
Li L
Yu X
author_facet Di J
Li X
Yang J
Li L
Yu X
author_sort Di J
collection DOAJ
description Jiaqi Di,1 Xuanlin Li,1 Jingjing Yang,1 Luguang Li,2 Xueqing Yu2 1Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P.R, Henna University of Chinese Medicine, Zhengzhou, 450046, People’s Republic of China; 2Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, 450000, People’s Republic of ChinaCorrespondence: Xueqing Yu, Email yxqshi@163.comObjective: This study aims to evaluate the risk of bias (ROB) and reporting quality of idiopathic pulmonary fibrosis (IPF) prediction models by assessing characteristics of these models.Methods: The development and/or validation of IPF prognostic models were identified via an electronic search of PubMed, Embase, and Web of Science (from inception to 12 August, 2021). Two researchers independently assessed the risk of bias (ROB) and reporting quality of IPF prediction models based on the Prediction model Risk Of Bias Assessment Tool (PROBAST) and Transparent Reporting of a multivariable prognostic model for Individual Prognosis or Diagnosis (TRIPOD) checklist.Results: Twenty prognostic model studies for IPF were included, including 7 (35%) model development and external validation studies, 8 (40%) development studies, and 5 (25%) external validation studies. According to PROBAST, all studies were appraised with high ROB, because of deficient reporting in the domains of participants (45.0%) and analysis (67.3%), and at least 55% studies were susceptible to 4 of 20 sources of bias. For the reporting quality, none of them completely adhered to the TRIPOD checklist, with the lowest mean reporting score for the methods and results domains (46.6% and 44.7%). For specific items, eight sub-items had a reporting rate ≥ 80% and adhered to the TRIPOD checklist, and nine sub-items had a very poor reporting rate, less than 30%.Conclusion: Studies adhering to PROBAST and TRIPOD checklists are recommended in the future. The reproducibility and transparency can be improved when studies completely adhere to PROBAST and TRIPOD checklists.Keywords: idiopathic pulmonary fibrosis, PROBAST, reporting quality, risk of bias, TRIPOD
first_indexed 2024-04-12T14:31:41Z
format Article
id doaj.art-9e03c33f46654fd58d3a1eb1868b87bb
institution Directory Open Access Journal
issn 1179-1594
language English
last_indexed 2024-04-12T14:31:41Z
publishDate 2022-06-01
publisher Dove Medical Press
record_format Article
series Risk Management and Healthcare Policy
spelling doaj.art-9e03c33f46654fd58d3a1eb1868b87bb2022-12-22T03:29:15ZengDove Medical PressRisk Management and Healthcare Policy1179-15942022-06-01Volume 151189120175807Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional StudyDi JLi XYang JLi LYu XJiaqi Di,1 Xuanlin Li,1 Jingjing Yang,1 Luguang Li,2 Xueqing Yu2 1Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P.R, Henna University of Chinese Medicine, Zhengzhou, 450046, People’s Republic of China; 2Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, 450000, People’s Republic of ChinaCorrespondence: Xueqing Yu, Email yxqshi@163.comObjective: This study aims to evaluate the risk of bias (ROB) and reporting quality of idiopathic pulmonary fibrosis (IPF) prediction models by assessing characteristics of these models.Methods: The development and/or validation of IPF prognostic models were identified via an electronic search of PubMed, Embase, and Web of Science (from inception to 12 August, 2021). Two researchers independently assessed the risk of bias (ROB) and reporting quality of IPF prediction models based on the Prediction model Risk Of Bias Assessment Tool (PROBAST) and Transparent Reporting of a multivariable prognostic model for Individual Prognosis or Diagnosis (TRIPOD) checklist.Results: Twenty prognostic model studies for IPF were included, including 7 (35%) model development and external validation studies, 8 (40%) development studies, and 5 (25%) external validation studies. According to PROBAST, all studies were appraised with high ROB, because of deficient reporting in the domains of participants (45.0%) and analysis (67.3%), and at least 55% studies were susceptible to 4 of 20 sources of bias. For the reporting quality, none of them completely adhered to the TRIPOD checklist, with the lowest mean reporting score for the methods and results domains (46.6% and 44.7%). For specific items, eight sub-items had a reporting rate ≥ 80% and adhered to the TRIPOD checklist, and nine sub-items had a very poor reporting rate, less than 30%.Conclusion: Studies adhering to PROBAST and TRIPOD checklists are recommended in the future. The reproducibility and transparency can be improved when studies completely adhere to PROBAST and TRIPOD checklists.Keywords: idiopathic pulmonary fibrosis, PROBAST, reporting quality, risk of bias, TRIPODhttps://www.dovepress.com/bias-and-reporting-quality-of-clinical-prognostic-models-for-idiopathi-peer-reviewed-fulltext-article-RMHPidiopathic pulmonary fibrosisprobastreporting qualityrisk of biastripod
spellingShingle Di J
Li X
Yang J
Li L
Yu X
Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
Risk Management and Healthcare Policy
idiopathic pulmonary fibrosis
probast
reporting quality
risk of bias
tripod
title Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
title_full Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
title_fullStr Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
title_full_unstemmed Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
title_short Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study
title_sort bias and reporting quality of clinical prognostic models for idiopathic pulmonary fibrosis a cross sectional study
topic idiopathic pulmonary fibrosis
probast
reporting quality
risk of bias
tripod
url https://www.dovepress.com/bias-and-reporting-quality-of-clinical-prognostic-models-for-idiopathi-peer-reviewed-fulltext-article-RMHP
work_keys_str_mv AT dij biasandreportingqualityofclinicalprognosticmodelsforidiopathicpulmonaryfibrosisacrosssectionalstudy
AT lix biasandreportingqualityofclinicalprognosticmodelsforidiopathicpulmonaryfibrosisacrosssectionalstudy
AT yangj biasandreportingqualityofclinicalprognosticmodelsforidiopathicpulmonaryfibrosisacrosssectionalstudy
AT lil biasandreportingqualityofclinicalprognosticmodelsforidiopathicpulmonaryfibrosisacrosssectionalstudy
AT yux biasandreportingqualityofclinicalprognosticmodelsforidiopathicpulmonaryfibrosisacrosssectionalstudy